| 【Company Research】InnoScience (2577 HK) - GaN-ning momentum one step at a time |
| 【Company Research】Angelalign (6699 HK) - Earnings beat with strong overseas momentum |
| 【Company Research】PICC P&C (2328 HK) - Non-auto CoR sees headroom for improvement |
| 【Company Research】Zoomlion (1157 HK/000157 CH) - First take: 2025 earnings +36% in-line; overseas revenue surged 60% in 4Q25 |
| 【Company Research】CR Beverage (2460 HK) - Expect earnings to bottom out in FY26E |
| 【Company Research】BYDE (285 HK) - Expect 2026 growth drivers from Apple Fold, auto business and AI server ramp-up |
| 【Company Research】Zenergy (3677 HK) - Brighter sales outlook after strong 2H25 earnings |
| 【Company Research】Leads Biolabs (9887 HK) - Expect multiple PoC data of LBL-024 in 2026 |
| 【Company Research】J&T Express (1519 HK) - 2025 earnings beat expectations; Market share further expanded |
| 【Company Research】DualityBio (9606 HK) - Pioneering ADC + IO 2.0 paradigm with next-generation blockbuster ADC |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
